<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
<journal-title>Frontiers in Psychiatry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Psychiatry</abbrev-journal-title>
<issn pub-type="epub">1664-0640</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpsyt.2025.1616996</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Effectiveness of pranayama for mental disorders: a systematic review and meta-analysis of randomized controlled trials</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>M&#xfc;tze</surname>
<given-names>Christian</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<uri xlink:href="https://loop.frontiersin.org/people/3138363/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mitzinger</surname>
<given-names>Dietmar</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Haller</surname>
<given-names>Heidemarie</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/797489/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Center for Integrative Medicine and Planetary Health, University Hospital Essen, University of Duisburg-Essen</institution>, <addr-line>Essen</addr-line>,&#xa0;<country>Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Neha Saboo, RUHS College of Medical Sciences, India</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Mark Dust, California State University, Fullerton, United States</p>
<p>Timothy John Pattiasina, Institut Informatika Indonesia, Indonesia</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Heidemarie Haller, <email xlink:href="mailto:heidemarie.haller@uk-essen.de">heidemarie.haller@uk-essen.de</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="ecorrected">
<day>12</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1616996</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>07</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 M&#xfc;tze, Mitzinger and Haller.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>M&#xfc;tze, Mitzinger and Haller</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>This review systematically assessed the evidence on the effectiveness and safety of pr&#x101;&#x1E47;&#x101;y&#x101;ma, traditional yogic breathing techniques, for patients diagnosed with mental disorders.</p>
</sec>
<sec>
<title>Methods</title>
<p>We searched PubMed, PsycINFO, and Central until April 2024. We calculated standardized mean differences (SMDs) with 95% confidence intervals (CIs) from both intention-to-treat (ITT) and per-protocol (PP) data for symptom severity (primary outcome) and health-related quality of life and depression (secondary outcomes) using Hedges&#x2019; correction for small samples. For risk of bias (RoB) assessment, we used the Cochrane RoB 2 tool.</p>
</sec>
<sec>
<title>Results</title>
<p>We included seven publications on six randomized controlled trials that examined 517 patients with posttraumatic stress disorder (PTSD), depression, and mixed non-psychotic mental disorders and compared pr&#x101;&#x1E47;&#x101;y&#x101;ma to passive controls (wait list and attention control) or standard care (psychotherapy, electroconvulsive therapy, and antidepressants). Overall RoB was assessed with some concerns in two studies and as high in four studies. The meta-analyses of the ITT samples (SMD = &#x2212;0.27, 95% CI = [&#x2212;0.52, &#x2212;0.03], I<sup>2</sup> = 10%) as well as the PP samples (SMD = &#x2212;0.35, 95% CI = [&#x2212;0.57, &#x2212;0.12], I<sup>2</sup> = 0%) showed that pr&#x101;&#x1E47;&#x101;y&#x101;ma significantly reduced post-intervention symptom severity in comparison to passive controls. When compared to standard care, both ITT and PP meta-analyses showed comparable results in reducing symptom severity. For secondary outcomes, only PP analyses on quality of life showed significantly higher post-intervention effects for pr&#x101;&#x1E47;&#x101;y&#x101;ma in comparison to passive controls (SMD = 0.59, 95% CI = [0.31, 0.87], I<sup>2</sup> = 20). No significant effects were found for depression. Sensitivity analyses excluding all studies with a high risk of overall bias revealed significant effects of pr&#x101;&#x1E47;&#x101;y&#x101;ma on symptom severity and quality of life, but only in PP samples and in comparison to passive controls. Adverse events were more frequently associated with fast than with slow breathing techniques.</p>
</sec>
<sec>
<title>Discussion</title>
<p>This meta-analysis suggests short-term effects of pr&#x101;&#x1E47;&#x101;y&#x101;ma when integrated in outpatient and inpatient care of mental disorders. In consideration of the overall high risk of bias and low number of analyzed patients, pr&#x101;&#x1E47;&#x101;y&#x101;ma should not be used instead of standard therapies. Further research is needed to explore long-term effects and adequately assess adverse events.</p>
</sec>
<sec>
<title>Protocol registration at Prospero</title>
<p>CRD42024550239</p>
</sec>
</abstract>
<kwd-group>
<kwd>pranayama</kwd>
<kwd>yogic breathing</kwd>
<kwd>yoga</kwd>
<kwd>mental disorders</kwd>
<kwd>complementary medicine</kwd>
<kwd>integrative medicine</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="46"/>
<page-count count="13"/>
<word-count count="5703"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Anxiety and Stress Disorders</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The rapid increase in psychological disorders over recent decades has become a critical global challenge, profoundly affecting healthcare systems, societies, and individuals worldwide (<xref ref-type="bibr" rid="B1">1</xref>). Psychological disorders, such as depression, anxiety, and posttraumatic stress disorder (PTSD), are among the leading causes of disability on a global scale (<xref ref-type="bibr" rid="B2">2</xref>). Lifetime prevalence rates are significant, impacting 28.6% of men and 29.8% of women, with the risk of developing a mental disorder by age 75 reaching 46.4% for men and 53.1% for women (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>Conventional treatment approaches for psychological disorders, such as cognitive&#x2013;behavioral therapy (CBT) and pharmacological interventions, are widely recommended as first-line treatments. However, their efficacy often remains modest, with meta-analyses revealing effect sizes of 0.34 for CBT and 0.36 for medication in comparison to treatment-as-usual or placebo (<xref ref-type="bibr" rid="B4">4</xref>). Pharmacological treatments, moreover, are frequently associated with side effects such as weight gain, fatigue, and sexual dysfunction (<xref ref-type="bibr" rid="B5">5</xref>). As mental health disorders continue to rise, we need more innovative and integrative treatment approaches combining standard therapies with evidence-based practices from traditional Chinese, Indian, or European medicine (<xref ref-type="bibr" rid="B6">6</xref>). With nearly half of the population in developed countries and similar or higher proportions in developing nations, the interest in and use of complementary treatments is evident (<xref ref-type="bibr" rid="B7">7</xref>), in particular in mental disorders (<xref ref-type="bibr" rid="B8">8</xref>), highlighting the need for research to evaluate the effectiveness and safety of complementary and integrative medicine (CIM).</p>
<p>Among CIM approaches, yoga is recognized for its accessibility, low risk of side effects, and potential benefits for stress and mental health (<xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>). Similarly, breathwork techniques have demonstrated significant effects on self-reported stress, anxiety, and depression (<xref ref-type="bibr" rid="B12">12</xref>). However, no meta-analysis has specifically evaluated pr&#x101;&#x1E47;&#x101;y&#x101;ma&#x2014;the Sanskrit term for breath-based yoga techniques. We therefore aimed to evaluate the effectiveness and safety of pr&#x101;&#x1E47;&#x101;y&#x101;ma in improving mental health outcomes in individuals diagnosed with mental disorders according to the <italic>Diagnostic and Statistical Manual of Mental Disorders</italic> (DSM) or the <italic>International Classification of Diseases</italic> (ICD).</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<p>This review followed the updated Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (<xref ref-type="bibr" rid="B13">13</xref>) and adhered to the Cochrane Collaboration&#x2019;s recommendations (<xref ref-type="bibr" rid="B14">14</xref>). We pre-registered the methodology on PROSPERO (CRD42024550239).</p>
<sec id="s2_1">
<title>Eligibility criteria</title>
<p>Studies were eligible if they were randomized controlled trials (RCTs) or clinical controlled trials (CCTs) with or without cross-over design, including adult patients (&#x2265;18 years) diagnosed with mental disorders as defined by ICD or DSM criteria or assessed through validated self-report measures. Due to the different diagnostic criteria that apply to children and adolescents, these samples were not considered. Studies were further included if pr&#x101;&#x1E47;&#x101;y&#x101;ma techniques were applied as a standalone intervention, excluding studies that combined pr&#x101;&#x1E47;&#x101;y&#x101;ma with other yoga components (except for relaxation) or other treatments that were not provided to both of the groups. There were no predefined criteria for intervention duration or frequency to capture a comprehensive range of the existing evidence. Eligible control interventions consisted of inactive and active comparators such as treatment as usual, wait list, attention control interventions, pharmacological treatments, or other non-pharmacological comparators. To be included, studies had to report at least one of the following outcomes: the primary outcome was symptom severity of the primary diagnosis, while secondary outcomes included health-related quality of life, depression, and safety. When multiple instruments were used to assess the same outcome in a study, preference was given to disease-specific over generic instruments, multi-item over single-item measures, and clinician-reported over patient-reported tools. Beyond that, the primary outcomes of the individual studies were favored over secondary ones. Safety was operationalized by the number of adverse events (AEs) or study withdrawals due to AEs. AEs were defined as any unfavorable medical event experienced by a participant, regardless of whether it was caused by the intervention. Events leading to death, life-threatening conditions, hospitalization, or substantial disability were classified as serious AEs (<xref ref-type="bibr" rid="B15">15</xref>).</p>
</sec>
<sec id="s2_2">
<title>Literature search</title>
<p>We systematically searched PubMed, PsycINFO, and the Cochrane Central Register of Controlled Trials until April 2024 without language or date restrictions. The search strategy (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>) included mesh and title/abstract searching for yoga and pr&#x101;&#x1E47;&#x101;y&#x101;ma terms combined with those for CCTs and RCTs and was adapted for each of the databases. We also searched gray literature through ResearchRabbit and international trial registries of the National Institutes of Health (NIC) and World Health Organization (WHO). Following the PRISMA guidelines (<xref ref-type="bibr" rid="B13">13</xref>), two reviewers (CM and HH) independently screened titles and abstracts of studies and assessed full texts for eligibility. Any disagreements were rechecked with a third reviewer (DM) until consensus was reached.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Search terms for PubMed.</p>
</caption>
<table frame="hsides">
<tbody>
<tr>
<td valign="top" align="left">#1</td>
<td valign="top" align="left">(yoga[Mesh] AND (breath*[tiab] OR respirat*[tiab] OR diaphragm*[tiab])) OR (breathing exercises[Mesh] AND (yoga[tiab] OR yogic[tiab] OR prana*[tiab])) OR (respiration therapy[Mesh] AND (yoga[tiab] OR yogic[tiab] OR prana*[tiab])) OR prana*[tiab] OR (yoga[tiab] AND (breath*[tiab] OR respirat*[tiab] OR diaphragm*[tiab])) OR (yogic[tiab] AND (breath*[tiab] OR respirat*[tiab] OR diaphragm*[tiab]))</td>
</tr>
<tr>
<td valign="top" align="left">#2</td>
<td valign="top" align="left">randomized controlled trial [pt] OR controlled clinical trial [pt] OR random* [tiab] OR placebo [tiab] OR sham [tiab] OR trial* [tiab] OR group* [tiab]</td>
</tr>
<tr>
<td valign="top" align="left">#3</td>
<td valign="top" align="left">#1 AND #2</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_3">
<title>Data extraction</title>
<p>Two reviewers (CM and DM) independently extracted data on study characteristics, including trial type, study origin, population characteristics, randomized sample size, mean age &#xb1; standard deviation (SD), percentage of female participants, treatment duration, intervention details, assessment points, outcomes included and not included in the meta-analysis, and funding sources. Discrepancies were rechecked by a third reviewer (HH) until consensus was reached. Missing study data were requested from the study authors by email.</p>
</sec>
<sec id="s2_4">
<title>Risk of bias in individual studies</title>
<p>The revised Cochrane risk-of-bias tool (RoB 2) (<xref ref-type="bibr" rid="B16">16</xref>) was used to assess the risk of bias in each included study across five domains: 1) bias arising from the randomization process, 2) bias due to deviations from intended interventions, 3) bias due to missing outcome data, 4) bias in the measurement of the outcome, and 5) bias in the selection of the reported result. Two reviewers (CM and DM) independently assessed each domain, and any discrepancies were resolved through discussion with a third reviewer (HH) to reach consensus. Each domain was rated as &#x201c;low risk of bias&#x201d;, &#x201c;some concerns&#x201d;, or &#x201c;high risk of bias&#x201d; according to the RoB 2 guidelines. An overall risk-of-bias judgment was derived based on domain-level ratings. Bias impact was visualized using the RoBvis tool (<xref ref-type="bibr" rid="B17">17</xref>).</p>
</sec>
<sec id="s2_5">
<title>Risk of bias across studies</title>
<p>We initially planned to evaluate the evidence of publication bias using Egger&#x2019;s test. However, since the number of included studies for each meta-analysis was fewer than 10, it was not possible to assess publication bias.</p>
</sec>
<sec id="s2_6">
<title>Qualitative and quantitative synthesis</title>
<p>The qualitative synthesis included a detailed comparison of study characteristics and risk of bias. As safety data were reported insufficiently, we decided against meta-analyzing data and reported AEs qualitatively.</p>
<sec id="s2_6_1">
<title>Quantitative synthesis of overall effect sizes</title>
<p>A pairwise meta-analysis was performed using Cochrane Review Manager (RevMan, Version 5.4.1). Where studies provided the same type of intervention and category of comparator (passive controls versus standard care), with the same outcome (which can be measured by different instruments) at the same assessment point (post-intervention and latest follow-up), the results were pooled using random-effects models to account for expected heterogeneity across the included studies. This approach assumes that true effect sizes may vary between studies due to clinical or methodological differences and estimates an average effect while incorporating between-study variance into the weighting of individual studies. Effects were displayed as standardized mean differences (SMDs) and 95% confidence intervals (CIs), adjusted by Hedges&#x2019; correction for small samples (<xref ref-type="bibr" rid="B14">14</xref>). Following Cohen&#x2019;s benchmarks (<xref ref-type="bibr" rid="B18">18</xref>), Hedges&#x2019; g values were interpreted as small (0.2&#x2013;0.5), medium (0.5&#x2013;0.8), or large (&gt;0.8), with respective readings for negative SMDs. For symptom severity and depression, a negative SMD indicated a greater improvement in pr&#x101;&#x1E47;&#x101;y&#x101;ma compared to controls, whereas a positive SMD indicated greater improvements in quality of life. Heterogeneity between effect estimators was assessed using the chi<sup>2</sup> test and the I<sup>2</sup> statistic. An I<sup>2</sup> value greater than 50% was considered indicative of substantial heterogeneity (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B19">19</xref>).</p>
</sec>
<sec id="s2_6_2">
<title>Subgroup analyses</title>
<p>We considered analyzing subgroups of patients who fully adhered to the intervention protocol [per-protocol (PP)] in contrast to all patients who were intended to be treated regardless of whether they completed the outcome assessment or adhered fully to the intervention [intention-to-treat (ITT)]. Initially, we also planned to analyze subgroups of patients with different mental disorders. However, due to the low number of available studies, this was not possible.</p>
</sec>
<sec id="s2_6_3">
<title>Sensitivity analyses</title>
<p>We conducted sensitivity analyses based on study quality for studies with a high risk of bias versus low risk/some concerns of overall bias. If at least substantial statistical heterogeneity was present in a respective meta-analysis, we used sensitivity analyses as well to explore heterogeneity in effect estimates according to study quality, study populations, and intervention characteristics.</p>
</sec>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Literature search</title>
<p>The electronic database search revealed 2,973 articles (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). Five additional articles were retrieved from ResearchRabbit. After removing duplicates and excluding articles by screening titles and abstracts, 16 full-text articles were assessed for eligibility. Nine full texts were excluded for the following reasons: six articles examined pr&#x101;&#x1E47;&#x101;y&#x101;ma combined with other yoga elements or interventions (<xref ref-type="bibr" rid="B20">20</xref>&#x2013;<xref ref-type="bibr" rid="B25">25</xref>), two articles lacked suitable control groups by including healthy adults or no control condition (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>), and one article included participants with burnout, which is not defined as a mental disorder (<xref ref-type="bibr" rid="B28">28</xref>). Thus, a final sample of seven articles on six individual datasets, including 517 patients, was included for qualitative and quantitative synthesis (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B35">35</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Flowchart of the literature search.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-g001.tif">
<alt-text content-type="machine-generated">Flowchart illustrating a study selection process. Identification: 2,973 records found, including from databases like PubMed and PsychInfo, and five from Research Rabbit. After removing 646 duplicates, 2,327 records were screened. Screening excluded 2,316 records; 16 reports were sought and assessed. No reports were not retrieved. Nine reports were excluded for reasons like lack of suitable groups or no mental disorder. Included studies: six in review, seven reports total.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_2">
<title>Study characteristics</title>
<p>The characteristics of the included studies are presented in <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>. All studies were RCTs conducted between 2000 and 2023 in the USA (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B33">33</xref>), India (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>), and Germany (<xref ref-type="bibr" rid="B31">31</xref>). Patients were civilians (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B35">35</xref>), veterans (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B33">33</xref>), and prisoners (<xref ref-type="bibr" rid="B34">34</xref>) suffering from various mental disorders, including PTSD (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B33">33</xref>), depression (<xref ref-type="bibr" rid="B32">32</xref>), alcohol dependence disorder (<xref ref-type="bibr" rid="B35">35</xref>), and mixed non-psychotic mental disorders (<xref ref-type="bibr" rid="B34">34</xref>). Sample sizes varied from 21 to 232, with a median of 67 participants and a median of 6% female participants. The average age across studies was 40.2 years, ranging from 28.7 to 56.9 years. The duration and frequency of pr&#x101;&#x1E47;&#x101;y&#x101;ma sessions varied by setting and population between 1 and 6 weeks, with an average of 17.5 sessions, while one study did not report duration in weeks but in sessions of 10 (<xref ref-type="bibr" rid="B31">31</xref>). Six out of the seven studies implemented Sudar&#x15b;an Kriy&#x101; Yoga (SKY) as a standardized protocol (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B32">32</xref>&#x2013;<xref ref-type="bibr" rid="B35">35</xref>), although the frequency and types of breathing exercises varied from low to fast/high frequency. The remaining study used a tailored protocol consisting of four specific pr&#x101;&#x1E47;&#x101;y&#x101;ma exercises (<xref ref-type="bibr" rid="B31">31</xref>): one fast breathing technique of high frequency, two slow-breathing ones, and one breath-holding technique (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>). Control conditions included passive ones such as wait list (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B35">35</xref>) and attention control (<xref ref-type="bibr" rid="B34">34</xref>) as well as standard treatments such as cognitive processing therapy (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>), electroconvulsive therapy (<xref ref-type="bibr" rid="B32">32</xref>), and antidepressant drugs (<xref ref-type="bibr" rid="B32">32</xref>). In the latter study, the data of the two control groups were combined to avoid biasing the final sample size. Similarly, one study (<xref ref-type="bibr" rid="B31">31</xref>) provided two measurements for the same endpoint (physical and psychological quality of life) that were pooled to provide a single value.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Study characteristics.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Reference</th>
<th valign="top" align="left">Trial type</th>
<th valign="top" align="left">Origin</th>
<th valign="top" align="left">Population</th>
<th valign="top" align="left">Sample size</th>
<th valign="top" align="left">Female</th>
<th valign="top" align="left">Mean age &#xb1; SD</th>
<th valign="top" align="left">Treatment duration</th>
<th valign="top" align="left">Assessment points</th>
<th valign="top" align="left">Treatment group</th>
<th valign="top" align="left">Control group</th>
<th valign="top" align="left">Outcomes included in meta-analysis</th>
<th valign="top" align="left">Outcomes not included in meta-analysis</th>
<th valign="top" align="left">Funding</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Bayley (2022) (<xref ref-type="bibr" rid="B29">29</xref>) and Schulz-Heik (2022) (<xref ref-type="bibr" rid="B30">30</xref>)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">USA</td>
<td valign="top" align="left">Veteran outpatients with PTSD + comorbid AD, AUD, and SUD</td>
<td valign="top" align="left">85</td>
<td valign="top" align="left">12%</td>
<td valign="top" align="left">56.9 <bold>&#xb1;</bold> 12.8</td>
<td valign="top" align="left">5 weeks</td>
<td valign="top" align="left">PI: 6 weeks<break/>FU: 12 months</td>
<td valign="top" align="left">Sudar&#x15b;an Kriy&#x101; Yoga</td>
<td valign="top" align="left">Cognitive processing therapy</td>
<td valign="top" align="left">&#x2212;Symptom severity (PCL-5)<sup>P#</sup>
<break/>&#x2212;Quality of life (VQ-P)<sup>P</sup>
<break/>&#x2212;Depression (BDI-II)<sup>P</sup>
<break/>&#x2212;Safety (AEs)<sup>P</sup>
</td>
<td valign="top" align="left">&#x2212;PTSD severity (CAPS-5)<sup>C&#x2021;</sup>
<break/>&#x2212;Quality of life (VQ-O)<sup>P</sup>
</td>
<td valign="top" align="left">Government</td>
</tr>
<tr>
<td valign="top" align="left">Haller (2023) (<xref ref-type="bibr" rid="B31">31</xref>)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">Germany</td>
<td valign="top" align="left">Civilian outpatients with PTSD</td>
<td valign="top" align="left">74</td>
<td valign="top" align="left">84%</td>
<td valign="top" align="left">44.2 &#xb1; 13.0</td>
<td valign="top" align="left">10 sessions</td>
<td valign="top" align="left">PI: after 10 sessions</td>
<td valign="top" align="left">Pr&#x101;&#x1E47;&#x101;y&#x101;ma + cognitive behavioral therapy</td>
<td valign="top" align="left">WL + cognitive behavioral therapy</td>
<td valign="top" align="left">&#x2212;Symptom severity (PCL-5)<sup>P#</sup>
<break/>&#x2212;Quality of Life (SF-12)<sup>P</sup>
<break/>&#x2212;Depression (BDI-II)<sup>P</sup>
<break/>&#x2212;Safety (AEs)<sup>P/C</sup>
</td>
<td valign="top" align="left">-None</td>
<td valign="top" align="left">University</td>
</tr>
<tr>
<td valign="top" align="left">Janakiramaiah (2000) (<xref ref-type="bibr" rid="B32">32</xref>)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">India</td>
<td valign="top" align="left">Civilian inpatients with depression</td>
<td valign="top" align="left">45</td>
<td valign="top" align="left">44%</td>
<td valign="top" align="left">38.7 &#xb1; 7.4</td>
<td valign="top" align="left">4 weeks</td>
<td valign="top" align="left">PI: 4 weeks</td>
<td valign="top" align="left">Sudar&#x15b;an Kriy&#x101; Yoga</td>
<td valign="top" align="left">&#x2212;Electroconvulsive therapy<break/>&#x2212;Imipramine</td>
<td valign="top" align="left">&#x2212;Symptom severity (HDRS)<sup>C#</sup>
<break/>&#x2212;Depression (HDRS)<sup>C#</sup>
<break/>&#x2212;Safety (AEs)<sup>C</sup>
</td>
<td valign="top" align="left">Depression (BDI)<sup>P</sup>
</td>
<td valign="top" align="left">N.r.</td>
</tr>
<tr>
<td valign="top" align="left">Sepp&#xe4;l&#xe4;&#xa0;(2014)&#xa0;(<xref ref-type="bibr" rid="B33">33</xref>)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">USA</td>
<td valign="top" align="left">Veteran outpatients with PTSD</td>
<td valign="top" align="left">21</td>
<td valign="top" align="left">0%</td>
<td valign="top" align="left">28.7 &#xb1; 4</td>
<td valign="top" align="left">1 week</td>
<td valign="top" align="left">PI: 1 week<break/>FU: 48 weeks</td>
<td valign="top" align="left">Sudar&#x15b;an Kriy&#x101; Yoga</td>
<td valign="top" align="left">WL</td>
<td valign="top" align="left">&#x2212;Symptom severity (PCL-M)<sup>P#</sup>
<break/>&#x2212;Depression (MASQ subscales GDD+AD)<sup>P</sup>
<break/>&#x2212;Safety (AEs)<sup>C</sup>
</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left">Trust</td>
</tr>
<tr>
<td valign="top" align="left">Sureka (2014) (<xref ref-type="bibr" rid="B34">34</xref>)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">India</td>
<td valign="top" align="left">Prisoners with mixed mental disorders (OCD, GAD, MDD, SD, AJD, and HID)</td>
<td valign="top" align="left">230</td>
<td valign="top" align="left">0%</td>
<td valign="top" align="left">36.1 &#xb1; 11.4</td>
<td valign="top" align="left">6 weeks</td>
<td valign="top" align="left">PI: 6 weeks</td>
<td valign="top" align="left">Sudar&#x15b;an Kriy&#x101; Yoga</td>
<td valign="top" align="left">Attention control (sitting&#xa0;with&#xa0;attention to the breath)</td>
<td valign="top" align="left">&#x2212;Symptom severity (GAFP)<sup>C</sup>
<break/>&#x2212;Quality of life (PGWB)<sup>P</sup>
<break/>&#x2212;Safety (AEs)<sup>C</sup>
</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left">N.r.</td>
</tr>
<tr>
<td valign="top" align="left">Vedamurthachar (2006) (<xref ref-type="bibr" rid="B35">35</xref>)</td>
<td valign="top" align="left">RCT</td>
<td valign="top" align="left">India</td>
<td valign="top" align="left">Civilian inpatients with ADS</td>
<td valign="top" align="left">60</td>
<td valign="top" align="left">0%</td>
<td valign="top" align="left">36.7 &#xb1; 7.7</td>
<td valign="top" align="left">2 weeks</td>
<td valign="top" align="left">PI: 3 weeks</td>
<td valign="top" align="left">Sudar&#x15b;an Kriy&#x101; Yoga</td>
<td valign="top" align="left">WL</td>
<td valign="top" align="left">&#x2212;Depression (BDI)<sup>P#</sup>
<break/>&#x2212;Safety (AEs)<sup>C</sup>
</td>
<td valign="top" align="left">None</td>
<td valign="top" align="left">Hospital</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>AA, anxious arousal; AD, anxiety disorder; AJD, adjustment disorder; AEs, adverse events; ADS, alcohol dependence syndrome; AUD, alcohol use disorder; BDI/II, Beck Depression Inventory/2nd Revision; CAPS-5, Clinician-administered PTSD Scale for DSM-5; FU, latest follow-up; GAD, generalized anxiety disorder; GAF, Global Assessment of Functioning Scale; HDRS, Hamilton Depression Rating Scale; HID, Habit and Impulse Disorder; MDD, major depressive disorder; MASQ-AD/GDD, Mood and Anxiety Symptoms Questionnaire, Anhedonic Depression Subscale/General Distress-Depressive Subscale; N.r., not reported; OCD, obsessive compulsive disorder; PCL-5/M, Posttraumatic Stress Disorder Checklist for DSM-5 Civilian Version/Military Version; PGWB, Psychological General Well Being Schedule; PI, post-intervention; PTSD, posttraumatic stress disorder; RCT, randomized controlled trial; SD, somatoform disorder; SF-12, Short Form 12 Health Survey; SUD, substance use disorder; VQ-P, Valuing Questionnaire Progress; VQ-O, Valuing Questionnaire Obstruction; WL, wait list.</p>
</fn>
<fn>
<p>Special characters: <sup>P</sup>, patient-reported outcome; <sup>C</sup>, clinician-administered outcome; <sup>#</sup>, Primary outcome(s) of the study; <sup>&#x2021;</sup>, Data not published and trial authors did not respond to email request.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Detailed characteristics of pr&#x101;&#x1E47;&#x101;y&#x101;ma interventions.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Reference</th>
<th valign="top" align="left">Pr&#x101;&#x1E47;&#x101;y&#x101;ma techniques <break/>used</th>
<th valign="top" align="left">Session characteristics</th>
<th valign="top" align="left">Setting</th>
<th valign="top" align="left">Instructor background</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Bayley (2022) (<xref ref-type="bibr" rid="B29">29</xref>) and Schulz-Heik (2022) (<xref ref-type="bibr" rid="B30">30</xref>)</td>
<td valign="top" align="left">&#x2212;N&#x0101;&#x1E0D;&#x012B; &#x15b;odhana (slow)<break/>&#x2212;&#x15a;&#x12b;tal&#x12b; (slow)<break/>&#x2212;Ujj&#x101;y&#x12b; (slow)<break/>&#x2212;Bhastrik&#x101; (fast)<break/>&#x2212;Sudar&#x15b;an kriy&#x101; (slow and fast)</td>
<td valign="top" align="left">Initial 5-day group workshop (3 hours per day) + 10 sessions of 60&#xa0;min, twice weekly over 6 weeks</td>
<td valign="top" align="left">Outpatient, group setting</td>
<td valign="top" align="left">Certified instructors by the Project Welcome Home Troops</td>
</tr>
<tr>
<td valign="top" align="left">Haller (2023) (<xref ref-type="bibr" rid="B31">31</xref>)</td>
<td valign="top" align="left">&#x2212;N&#x0101;&#x1E0D;&#x012B; &#x15b;odhana (slow)<break/>&#x2212;Ujj&#x101;y&#x12b; (slow)<break/>&#x2212;Kap&#x101;labh&#x101;t&#x12b; (fast)<break/>&#x2212;Kumbhaka (retention)</td>
<td valign="top" align="left">10 sessions of 5&#x2013;10 min over consecutive therapy units</td>
<td valign="top" align="left">Outpatient, one-to-one setting</td>
<td valign="top" align="left">Psychotherapists with additional training in yoga therapy</td>
</tr>
<tr>
<td valign="top" align="left">Janakiramaiah (2000) (<xref ref-type="bibr" rid="B32">32</xref>)</td>
<td valign="top" align="left">&#x2212;Ujj&#x101;y&#x12b; (slow)<break/>&#x2212;Bhastrik&#x101; (fast)<break/>&#x2212;Sudar&#x15b;an kriy&#x101; (slow and fast)</td>
<td valign="top" align="left">4&#x2013;6&#xd7;/week over 4 weeks of 30 min</td>
<td valign="top" align="left">Inpatient, group setting</td>
<td valign="top" align="left">Yoga teacher trained by the Art of Living Foundation</td>
</tr>
<tr>
<td valign="top" align="left">Sepp&#xe4;l&#xe4; (2014) (<xref ref-type="bibr" rid="B33">33</xref>)</td>
<td valign="top" align="left">&#x2212;Ujj&#x101;y&#x12b; (slow)<break/>&#x2212;Bhastrik&#x101; (fast)<break/>&#x2212;Sudar&#x15b;an kriy&#x101; (slow and fast)</td>
<td valign="top" align="left">3 &#xd7;1-hour group sessions daily over 7 days</td>
<td valign="top" align="left">Outpatient, group setting</td>
<td valign="top" align="left">Certified instructors by the Project Welcome Home Troops</td>
</tr>
<tr>
<td valign="top" align="left">Sureka (2014) (<xref ref-type="bibr" rid="B34">34</xref>)</td>
<td valign="top" align="left">N&#x0101;&#x1E0D;&#x012B; &#x15b;odhana (slow)<break/>&#x2212;Ujj&#x101;y&#x12b; (slow)<break/>&#x2212;Bhastrik&#x101; (fast)<break/>&#x2212;Sudar&#x15b;an kriy&#x101; (slow and fast)</td>
<td valign="top" align="left">5 sessions per week of 30&#xa0;min over 6 weeks</td>
<td valign="top" align="left">Prison, group setting</td>
<td valign="top" align="left">Certified yoga teachers by the Art of Living Foundation</td>
</tr>
<tr>
<td valign="top" align="left">Vedamurthachar (2006) (<xref ref-type="bibr" rid="B35">35</xref>)</td>
<td valign="top" align="left">&#x2212;Ujj&#x101;y&#x12b; (slow)<break/>&#x2212;Bhastrik&#x101; (fast)<break/>&#x2212;Sudar&#x15b;an kriy&#x101; (slow and fast)</td>
<td valign="top" align="left">7 sessions of 45&#x2013;60 min (every other day) over 2 weeks</td>
<td valign="top" align="left">Inpatient, group setting</td>
<td valign="top" align="left">Therapists trained by the Art of Living Foundation</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Explanation of Sanskrit names: Bhastrik&#x101;, bellows breathing; Kap&#x101;labh&#x101;t&#x12b;, passive inspiration with forceful expiration; Kumbhaka, holding of the breath until the breathing reflex prevailed over volition; N&#x0101;&#x1E0D;&#x012B; &#x15b;odhana, alternate nostril breathing; &#x15a;&#x12b;tal&#x12b;, straw breathing; Ujj&#x101;y&#x12b;, deep breathing with trachea contraction; Sudar&#x15b;an kriy&#x101;, rhythmic cyclic breathing.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Regarding data analysis, two studies presented findings for both PP and ITT populations: one applying the last observation carried forward method (<xref ref-type="bibr" rid="B29">29</xref>) and the other using fully conditional specification iterations (<xref ref-type="bibr" rid="B31">31</xref>). Four studies reported values that could be interpreted as ITT ones due to no (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B35">35</xref>) or minimal dropout rates of n = 1 per group (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>), while one study (<xref ref-type="bibr" rid="B30">30</xref>) conducted only exploratory PP analysis.</p>
</sec>
<sec id="s3_3">
<title>Risk of bias of individual studies</title>
<p>RoB is summarized in <xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>. Overall, RoB was high in four studies (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B35">35</xref>) and assessed with some concerns in two studies (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Regarding bias from the randomization process, only one study (<xref ref-type="bibr" rid="B31">31</xref>) provided a clear description of the allocation procedure. In contrast, one study (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>) excluded participants directly after randomization without explanation, potentially introducing bias. For the remaining studies (<xref ref-type="bibr" rid="B32">32</xref>&#x2013;<xref ref-type="bibr" rid="B35">35</xref>), information was insufficient to adequately assess the entire randomization process.</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Risk of bias of individual studies.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="bottom" align="center">
</th>
<th valign="bottom" align="center">D1</th>
<th valign="bottom" align="center">D2</th>
<th valign="bottom" align="center">D3</th>
<th valign="bottom" align="center">D4</th>
<th valign="bottom" align="center">D5</th>
<th valign="bottom" align="center">Overall</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Bayley (2022) (<xref ref-type="bibr" rid="B29">29</xref>) and Schulz-Heik (2022) (<xref ref-type="bibr" rid="B30">30</xref>)</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i003.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i002.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
</tr>
<tr>
<td valign="middle" align="left">Haller (2023) (<xref ref-type="bibr" rid="B31">31</xref>)</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i003.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i002.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i003.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i003.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i003.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i002.tif"/>
</td>
</tr>
<tr>
<td valign="middle" align="left">Janakiramaiah (2000) (<xref ref-type="bibr" rid="B32">32</xref>)</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i002.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i003.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i002.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
</tr>
<tr>
<td valign="middle" align="left">Sepp&#xe4;l&#xe4; (2014) (<xref ref-type="bibr" rid="B33">33</xref>)</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i002.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i003.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i002.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
</tr>
<tr>
<td valign="middle" align="left">Sureka (2014) (<xref ref-type="bibr" rid="B34">34</xref>)</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i002.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i003.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i003.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i003.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i002.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i002.tif"/>
</td>
</tr>
<tr>
<td valign="middle" align="left">Vedamurthachar (2006) (<xref ref-type="bibr" rid="B35">35</xref>)</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i002.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
<td valign="top" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
<td valign="middle" align="center">
<inline-graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-i001.tif"/>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Domains: D1, bias due to the randomization process; D2, deviation from intended intervention; D3, missing outcome data; D4, measurement of outcomes; D5, selection of the reported result.Judgement: X, High; -, Some concerns; +, Low.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Bias due to deviations from intended interventions was assessed as follows: due to the nature of the pr&#x101;&#x1E47;&#x101;y&#x101;ma intervention, participants and providers were aware of assignments in all studies. However, one study (<xref ref-type="bibr" rid="B34">34</xref>) ensured scientific rigor by including a suitable attention control group, while one study (<xref ref-type="bibr" rid="B31">31</xref>) considered statistical adjustments for patient expectation, raising only some concerns. The other four studies were rated as high risk, as the authors deviated from the protocol by excluding participants after randomization with an incomprehensible explanation (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>), did not provide sufficient information (<xref ref-type="bibr" rid="B32">32</xref>), or possibly introduced nocebo effects by not offering any control intervention other than wait list (<xref ref-type="bibr" rid="B35">35</xref>).</p>
<p>Bias due to missing outcome data was rated low in three studies because of minimal dropout rates (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>) or ITT analysis with robust imputation methods of missing data (<xref ref-type="bibr" rid="B31">31</xref>). The remaining three studies were rated as high risk, as they did not provide sufficient information (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B35">35</xref>) or excluded participants without justification (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>).</p>
<p>Measurement bias was generally low, as all studies used validated instruments with consistent methods and time points. However, in two studies (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B35">35</xref>), the absence of active control conditions may have influenced outcome assessments, indicating a high risk of bias.</p>
<p>Finally, selective outcome reporting was low in only one study (<xref ref-type="bibr" rid="B31">31</xref>) that fully adhered to a registered protocol. Four studies raised some concerns, as they differed slightly from the published protocol without adequate explanation (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>) or did not report pre-registered protocols but reported comprehensible outcome selection, which do not seem to be biased (<xref ref-type="bibr" rid="B32">32</xref>&#x2013;<xref ref-type="bibr" rid="B34">34</xref>). One study, however, reported using the Severity of Alcohol Dependence Questionnaire at baseline and follow-up, but only presented baseline values (<xref ref-type="bibr" rid="B35">35</xref>).</p>
</sec>
<sec id="s3_4">
<title>Quantitative synthesis</title>
<sec id="s3_4_1">
<title>Effects on symptom severity</title>
<p>Symptom severity was measured by clinician-administered and patient-reported instruments in patients with PTSD, depression, and mixed mental disorders. Compared to passive controls post-intervention, pr&#x101;&#x1E47;&#x101;y&#x101;ma resulted in significantly greater symptom reductions of small effect sizes in ITT samples (SMD = &#x2212;0.27, 95% CI = [&#x2212;0.52, &#x2212;0.03], I<sup>2</sup> = 10%, N = 324) as well as in PP ones (SMD = &#x2212;0.35, 95% CI = [&#x2212;0.57, &#x2212;0.12], I<sup>2</sup> = 0%, N = 315) (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>). When compared to standard care, meta-analyses in both ITT and PP samples showed non-significantly different results to pr&#x101;&#x1E47;&#x101;y&#x101;ma (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Forest plot of symptom severity. Legend: I<sup>2</sup>, heterogeneity; ITT, intention-to-treat population; CI, confidence interval; IV, inverse variance; PP, per-protocol population; SD, standard deviation. Note: Passive controls include wait list (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B33">33</xref>) and attention control (<xref ref-type="bibr" rid="B34">34</xref>) groups; standard care includes cognitive processing therapy (<xref ref-type="bibr" rid="B29">29</xref>), electroconvulsive therapy (<xref ref-type="bibr" rid="B32">32</xref>), and imipramine (<xref ref-type="bibr" rid="B32">32</xref>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-g002.tif">
<alt-text content-type="machine-generated">Forest plot comparing pranayama to passive controls and standard care in various studies. Subgroups and overall effects with confidence intervals are presented for intention-to-treat (ITT) and per-protocol analyses (PP). Risk of bias is indicated with colored symbols. The x-axis ranges from -2 to 2, showing effects favoring pranayama or control.</alt-text>
</graphic>
</fig>
<p>Follow-up data on PTSD severity were reported by two studies with different control conditions up to 12 months. One study (<xref ref-type="bibr" rid="B33">33</xref>) comparing pr&#x101;&#x1E47;&#x101;y&#x101;ma to wait list found a significant group&#x2013;time interaction, and the other one (<xref ref-type="bibr" rid="B29">29</xref>) reported non-inferiority of pr&#x101;&#x1E47;&#x101;y&#x101;ma against cognitive processing therapy.</p>
</sec>
<sec id="s3_4_2">
<title>Effects on secondary outcomes</title>
<p>Quality of life was assessed using patient-reported instruments in samples with PTSD and mixed mental disorders. Meta-analyses could be performed only for comparisons of pr&#x101;&#x1E47;&#x101;y&#x101;ma against passive controls and are shown in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>. Directly after the end of the intervention, pr&#x101;&#x1E47;&#x101;y&#x101;ma did not show significantly different effects in the ITT samples but did so in the PP samples (SMD = 0.59, 95% CI = [0.31, 0.87], I<sup>2</sup> = 20%, N = 295) (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B34">34</xref>). One further study reported quality of life data post-intervention against cognitive processing therapy and did not find statistically significant differences (<xref ref-type="bibr" rid="B30">30</xref>). For this outcome, follow-up data were not available.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Forest plot of quality of life. Legend: I<sup>2</sup>, heterogeneity; ITT, intention-to-treat population; CI, confidence interval; IV, inverse variance; PP, per-protocol population; SD, standard deviation. Passive controls include wait list (<xref ref-type="bibr" rid="B31">31</xref>) and attention control (<xref ref-type="bibr" rid="B34">34</xref>) groups.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-g003.tif">
<alt-text content-type="machine-generated">Forest plot comparing Pranayama versus passive controls in two studies, Haller 2023 and Sureka 2014, with both ITT and PP groups. The standardized mean differences and confidence intervals are displayed with box plots and a diamond summary. The ITT group shows a subtotal effect size of 0.40 with heterogeneity I-squared of 82 percent. The PP group shows a subtotal effect size of 0.59 with heterogeneity I-squared of 20 percent. Both groups indicate no significant overall risk of bias. The plot suggests a favorable outcome for Pranayama in both analyses.</alt-text>
</graphic>
</fig>
<p>Depression was assessed using clinician-administered and patient-reported instruments in participants with PTSD, depression, and alcohol dependence disorder. The pooled effects on depression are shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>. Compared with passive controls as well as standard care, pr&#x101;&#x1E47;&#x101;y&#x101;ma did not show any significant differences. Follow-up data were reported by two studies showing no significant group differences up to 12 months.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Forest plot of depression. Legend: I<sup>2</sup>, heterogeneity; ITT, intention-to-treat population; CI, confidence interval; IV, inverse variance; PP, per-protocol population; SD, standard deviation. Passive controls include wait list (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B35">35</xref>), and standard care includes cognitive processing therapy (<xref ref-type="bibr" rid="B29">29</xref>), electroconvulsive therapy (<xref ref-type="bibr" rid="B32">32</xref>), and imipramine (<xref ref-type="bibr" rid="B32">32</xref>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1616996-g004.tif">
<alt-text content-type="machine-generated">Forest plot comparing pranayama with passive controls and standard care in several studies. The plot includes three sections: ITT and PP comparisons. Each section displays the standard mean difference with confidence intervals. Squares represent individual study effects; diamonds show combined effects. Risk of bias for each study is indicated on the right, showing low to high risk levels. The x-axis depicts the standard mean difference from -2 to 2, where left favors pranayama and right favors control.</alt-text>
</graphic>
</fig>
<p>Safety data were reported insufficiently. Thus, we decided against meta-analyzing data and reported AEs qualitatively. While one study (<xref ref-type="bibr" rid="B31">31</xref>) assessed AEs and drop-outs by AEs systematically, the others did not. In this study, one patient of the wait list reported fatigue, while 15 patients of the pr&#x101;&#x1E47;&#x101;y&#x101;ma group reported minor AEs such as anxiety, breathlessness, cough, dizziness, feeling of constriction, flashback, headache, and neck pain, which had high probability of being associated with pr&#x101;&#x1E47;&#x101;y&#x101;ma, in particular with kap&#x101;labh&#x101;t&#x12b;, a fast/high-frequency breathing technique. Although these AEs were classified as minor and not recurrent, they led to drop-outs and significantly worse effects on selected study outcomes when compared to control patients. Of the 15 pr&#x101;&#x1E47;&#x101;y&#x101;ma patients with AEs, three AEs were serious ones and led to hospitalization in two patients (orofacial cleft surgery and stent implantation) and death in one patient (congenital heart defect), but were probably not associated with pr&#x101;&#x1E47;&#x101;y&#x101;ma (<xref ref-type="bibr" rid="B31">31</xref>). Another study reported no AEs within the pr&#x101;&#x1E47;&#x101;y&#x101;ma group and two within the group receiving cognitive processing therapy, of which one was considered serious (hospitalization for suicidal ideation) (<xref ref-type="bibr" rid="B29">29</xref>). The remaining studies (<xref ref-type="bibr" rid="B32">32</xref>&#x2013;<xref ref-type="bibr" rid="B35">35</xref>) reported no adverse events in either group.</p>
</sec>
</sec>
<sec id="s3_5">
<title>Sensitivity analyses</title>
<p>By excluding studies with a high risk of overall bias, only comparisons against passive controls remain in the analyses. For symptom severity, pooling effects of ITT samples no longer revealed significant group differences, and statistical heterogeneity increased (SMD = &#x2212;0.22, 95% CI = [&#x2212;0.57, 0.13], I<sup>2</sup> = 48%, N = 304) (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B34">34</xref>). By pooling the effects of PP samples, differences remain significant (SMD = &#x2212;0.33, 95% CI = [&#x2212;0.56, 0.10], I<sup>2</sup> = 0%, N = 295) (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B34">34</xref>). For quality of life, all main analyses were based on studies without a high risk of bias. Depression analyses are all based on studies with a high risk of bias, with one exception (<xref ref-type="bibr" rid="B31">31</xref>). Comparing the results of this individual study with the pooled effects, all revealed no significant difference between pr&#x101;&#x1E47;&#x101;y&#x101;ma and passive controls on depression.</p>
<p>Substantial statistical heterogeneity was observed in meta-analyses of quality of life and depression. As most analyses included only two studies, reducing heterogeneity by excluding studies was only possible for the comparison of pr&#x101;&#x1E47;&#x101;y&#x101;ma versus passive controls on depression. Here, statistical heterogeneity could only be reduced by excluding the study with the best quality and the highest number of patients, resulting in significant group differences within the ITT and PP samples. However, as these results are likely subject to substantial bias, the data were not shown.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<sec id="s4_1">
<title>Summary of evidence</title>
<p>The systematic search revealed seven RCTs on six samples investigating the effectiveness of pr&#x101;&#x1E47;&#x101;y&#x101;ma in patients diagnosed with mental disorders. Based on analyses of studies with overall some concerns of risk of bias, the evidence suggests that pr&#x101;&#x1E47;&#x101;y&#x101;ma may have small-to-medium short-term effects on symptom severity and quality of life when compared to passive controls. However, sensitivity analysis showed that when high-risk trials are excluded, the effects remain significant only for PP data, not ITT ones. Moreover, we did not find any effects of pr&#x101;&#x1E47;&#x101;y&#x101;ma on depression. Comparable effects of pr&#x101;&#x1E47;&#x101;y&#x101;ma against standard psycho- or pharmacotherapy should be interpreted with caution, as they were based on single or pooled high-risk studies. The same is true for long-term effects. Safety was reported insufficiently. Based on the reported data, pr&#x101;&#x1E47;&#x101;y&#x101;ma, in particular fast breathing, was associated with adverse events.</p>
</sec>
<sec id="s4_2" sec-type="discussion">
<title>Discussion of results</title>
<p>These findings align with a comprehensive systematic review and meta-analysis of 26 RCTs on breathwork and mental health in mixed populations of healthy individuals and somatically and mentally ill patients who revealed small-to-medium effects of modern and traditional forms of breathwork on self-reported stress, anxiety, and depression compared to non-breathwork active and passive controls (<xref ref-type="bibr" rid="B12">12</xref>). Likewise, our meta-analyses did not find any effects on depression. However, due to substantial heterogeneity in all of the analyses, this conclusion should be considered preliminary. The review further reported comparable effect sizes for different breathing techniques, in particular slow and fast breathing exercises, but only slow breathing resulted in significant pooled effects and was therefore recommended to patients. In our analyses, we were not able to differentiate between slow and fast pr&#x101;&#x1E47;&#x101;y&#x101;ma techniques because of the overall low number of studies and the combination of low and fast techniques in all of the included studies. However, we detected higher AEs of fast breathing techniques, especially kap&#x101;labh&#x101;t&#x12b;, which strengthened the prior recommendation. Another scoping review on breathwork for clinically diagnosed anxiety disorders also found significant symptom improvements, particularly with slow diaphragmatic breathing, while the results for fast hyperventilation techniques were contradictory (<xref ref-type="bibr" rid="B36">36</xref>). This can be explained by evidence showing that slow breathing enhances parasympathetic activity, improves vagal tone, and regulates emotional responses by modulating brain regions such as the prefrontal cortex and amygdala (<xref ref-type="bibr" rid="B37">37</xref>). Furthermore, slow breathing has been associated with increased alpha power in the electroencephalogram (EEG), reflecting states of relaxation and focused attention (<xref ref-type="bibr" rid="B38">38</xref>). These physiological mechanisms likely underpin the reductions in anxiety and stress observed following slow breathing interventions and suggest that pr&#x101;&#x1E47;&#x101;y&#x101;ma protocols emphasizing slow and controlled breathing techniques could improve therapeutic outcomes while minimizing adverse events associated with fast practices such as kap&#x101;labh&#x101;t&#x12b;. Nonetheless, fast breathing techniques have shown interesting effects as well. Although they did not lower cortisol levels initially but increased them, fast breathing showed a better long-term stabilization of cortisol levels and was discussed to act as a training impulse to the autonomic nervous system, similarly to physical exercises (<xref ref-type="bibr" rid="B39">39</xref>). By communicating possible AEs of fast breathing techniques to patients and adequately accompanying them, patients may equally or even better benefit from fast breathing techniques.</p>
</sec>
<sec id="s4_3">
<title>Limitations of the review</title>
<p>The first limitation is the small number of included studies with limited follow-up data. Conclusions, especially from meta-analyses that include only two RCTs, should therefore be considered preliminary. Substantial heterogeneity in some of the analyses suggests that additional studies are urgently needed to make precise and robust conclusions about the effectiveness of pr&#x101;&#x1E47;&#x101;y&#x101;ma, especially as a single intervention against standard care. Moreover, the absence of long-term data in all but two studies (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B33">33</xref>) limits the conclusions regarding the sustainability of the effects. In addition, given the limited number of studies, we were unable to assess the risk of publication bias, which cannot be excluded and should be considered in the interpretation of the findings.</p>
<p>A second limitation includes the risk of bias profile of the included studies. Although it was comparable with the profile of studies on conventional breathing interventions (<xref ref-type="bibr" rid="B12">12</xref>), only 33.3% of the domains could be assessed as low risk, and 27.8% raised some concerns, potentially impacting the internal validity of the studies as well as the generalization of the pooled results.</p>
<p>The third limitation refers to possible placebo effects that cannot be excluded because therapists cannot be blinded to treatment allocation, and analyses contained patient-reported outcomes, which may have been influenced by subjective perceptions and expectations. Only one study (<xref ref-type="bibr" rid="B31">31</xref>) controlled for patient expectations in statistical analyses. In contrast, none of the studies addressed other non-specific treatments and therapist effects, such as the therapeutic alliance, which can be controlled, for example, by using validated questionnaires (<xref ref-type="bibr" rid="B40">40</xref>).</p>
<p>Additional limitations include the insufficient reporting of adverse events and more favorable effects in small, high-risk studies from India (<xref ref-type="bibr" rid="B41">41</xref>), which may bias conclusions regarding the risk&#x2013;benefit ratio. Moreover, the predominance of male participants (94%) limits the generalizability of findings to female populations.</p>
</sec>
<sec id="s4_4">
<title>Implications for further research</title>
<p>Future studies should investigate both the efficacy and specific mechanisms of pr&#x101;&#x1E47;&#x101;y&#x101;ma in treating various psychological disorders in detail. Systematic reporting of AEs is essential to improve comparability and ensure a comprehensive understanding of pr&#x101;&#x1E47;&#x101;y&#x101;ma&#x2019;s safety in the treatment of mental disorders. Future studies should therefore include reporting of AEs according to the Consolidated Standards of Reporting Trials (CONSORT) extension for harms to ensure the standardized reporting of adverse events (<xref ref-type="bibr" rid="B42">42</xref>). The sustainability of treatment outcomes should also be evaluated by examining long-term effects. Recommendations further include the need for larger sample sizes, rigorous study designs, and the reporting of methodologies in accordance with CONSORT (<xref ref-type="bibr" rid="B43">43</xref>) to minimize the risk of bias. In addition, the Checklist Standardising the Reporting of Interventions For Yoga (CLARIFY) checklist (<xref ref-type="bibr" rid="B44">44</xref>) provides researchers with a minimum reporting template for yoga studies. If blinding of therapists is not feasible, attention effects could be controlled by asking patients about their perception of the therapeutic alliance using validated questionnaires. Moreover, further research should include diverse demographic groups. In this review, women were severely underrepresented, with a median of only 6%. Given the higher prevalence of mental health disorders in women (27.2%) than in men (18.1%) (<xref ref-type="bibr" rid="B45">45</xref>), this proportion should be accounted for in future studies. Moreover, future research should include more diverse populations beyond the currently studied groups (e.g., Indian clinical samples and U.S. veterans) to improve generalizability across cultural and demographic contexts. Future studies should also aim to clarify specific mechanisms of action by examining factors such as type of pr&#x101;&#x1E47;&#x101;y&#x101;ma (e.g., slow versus fast), session duration, intensity, and frequency. Additionally, future trials may directly compare pr&#x101;&#x1E47;&#x101;y&#x101;ma with established treatment approaches such as cognitive behavioral therapy or pharmacotherapy to determine comparative effectiveness. Together, these implications will contribute to drawing better conclusions about the efficacy, effectiveness, and safety of pr&#x101;&#x1E47;&#x101;y&#x101;ma for patients with mental disorders.</p>
</sec>
<sec id="s4_5">
<title>Implications for clinical practice</title>
<p>pr&#x101;&#x1E47;&#x101;y&#x101;ma, in particular slow breathing techniques, may decrease symptom severity and improve quality of life of non-psychotic mental disorders when integrated in out- and inpatient care. To date there is no robust evidence that pr&#x101;&#x1E47;&#x101;y&#x101;ma programs has comparable effects to standard treatments such as Cognitive Behavioral Therapy or Antidepressants and should therefore not be used instead of these therapies. Due to the considerable variability in the duration and frequency of pr&#x101;&#x1E47;&#x101;y&#x101;ma interventions across studies, no evidence-based recommendation regarding an optimal length or intensity of pr&#x101;&#x1E47;&#x101;y&#x101;ma can be made yet. Therapists should also be aware of possible side effects of fast breathing techniques, especially in patients with PTSD or anxiety disorders who might perceive these techniques as additional stressors or even trigger. Nevertheless, they might be useful to increase stress tolerance equally to the use of breath-holding tasks (<xref ref-type="bibr" rid="B46">46</xref>).</p>
</sec>
</sec>
</body>
<back>
<sec id="s5" sec-type="author-contributions">
<title>Author contributions</title>
<p>CM: Visualization, Writing &#x2013; original draft, Data curation, Conceptualization, Project administration, Formal analysis, Methodology, Writing &#x2013; review &amp; editing. DM: Formal analysis, Data curation, Writing &#x2013; review &amp; editing. HH: Supervision, Formal analysis, Data curation, Methodology, Visualization, Writing &#x2013; review &amp; editing, Conceptualization, Writing &#x2013; original draft.</p>
</sec>
<sec id="s6" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. The authors would like to acknowledge the support of the Open Access Publication Fund of the University of Duisburg-Essen, Germany. DM was supported by a research grant from the Steffen Lohrer Foundation. The funding source had no influence on the design and conduct of the meta-analysis; the collection, management, analysis, and interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.</p>
</sec>
<sec id="s7" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s8">
<title>Correction note</title>
<p>&#xfeff;This article has been corrected with minor changes. These changes do not impact the scientific content of the article.</p>
</sec>
<sec id="s9" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<collab>GBD 2019 Mental Disorders Collaborators</collab>
</person-group>. <article-title>Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019</article-title>. <source>Lancet Psychiatry</source>. (<year>2022</year>) <volume>9</volume>:<page-range>137&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2215-0366(21)00395-3</pub-id>, PMID: <pub-id pub-id-type="pmid">35026139</pub-id></citation></ref>
<ref id="B2">
<label>2</label>
<citation citation-type="book">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>. <source>Depression and other common mental disorders: global health estimates</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name> (<year>2017</year>).</citation></ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGrath</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Al-Hamzawi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Alonso</surname> <given-names>J</given-names>
</name>
<name>
<surname>Altwaijri</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Andrade</surname> <given-names>LH</given-names>
</name>
<name>
<surname>Bromet</surname> <given-names>EJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries</article-title>. <source>Lancet Psychiatry</source>. (<year>2023</year>) <volume>10</volume>:<page-range>668&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2215-0366(23)00193-1</pub-id>, PMID: <pub-id pub-id-type="pmid">37531964</pub-id></citation></ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leichsenring</surname> <given-names>F</given-names>
</name>
<name>
<surname>Steinert</surname> <given-names>C</given-names>
</name>
<name>
<surname>Rabung</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ioannidis</surname> <given-names>JPA</given-names>
</name>
</person-group>. <article-title>The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses</article-title>. <source>World Psychiatry</source>. (<year>2022</year>) <volume>21</volume>:<page-range>133&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/wps.20941</pub-id>, PMID: <pub-id pub-id-type="pmid">35015359</pub-id></citation></ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uher</surname> <given-names>R</given-names>
</name>
<name>
<surname>Farmer</surname> <given-names>A</given-names>
</name>
<name>
<surname>Henigsberg</surname> <given-names>N</given-names>
</name>
<name>
<surname>Rietschel</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mors</surname> <given-names>O</given-names>
</name>
<name>
<surname>Maier</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Adverse reactions to antidepressants</article-title>. <source>Br J Psychiatry</source>. (<year>2009</year>) <volume>195</volume>:<page-range>202&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1192/bjp.bp.108.061960</pub-id>, PMID: <pub-id pub-id-type="pmid">19721108</pub-id></citation></ref>
<ref id="B6">
<label>6</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Sarris</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gerbarg</surname> <given-names>PL</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Muskin</surname> <given-names>PR</given-names>
</name>
<name>
<surname>Tasman</surname> <given-names>A</given-names>
</name>
<name>
<surname>Riba</surname> <given-names>MB</given-names>
</name>
<etal/>
</person-group>. <article-title>Integrative and complementary medicine in psychiatry</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Tasman</surname> <given-names>A</given-names>
</name>
<name>
<surname>Riba</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Alarc&#xf3;n</surname> <given-names>RD</given-names>
</name>
<name>
<surname>Alfonso</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Kanba</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lecic-Tosevski</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>, editors. <source>Tasman&#x2019;s psychiatry</source>. <publisher-name>Springer International Publishing</publisher-name>, <publisher-loc>Cham</publisher-loc> (<year>2024</year>). p. <page-range>4537&#x2013;94</page-range>.</citation></ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seetharaman</surname> <given-names>M</given-names>
</name>
<name>
<surname>Krishnan</surname> <given-names>G</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>RH</given-names>
</name>
</person-group>. <article-title>The future of medicine: frontiers in integrative health and medicine</article-title>. <source>Medicina (Kaunas)</source>. (<year>2021</year>) <volume>57</volume>(<issue>12</issue>):<fpage>1079</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/medicina57121303</pub-id>, PMID: <pub-id pub-id-type="pmid">34946248</pub-id></citation></ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melzer</surname> <given-names>J</given-names>
</name>
<name>
<surname>Deter</surname> <given-names>H-C</given-names>
</name>
<name>
<surname>Uehleke</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>CAM in psychiatry</article-title>. <source>Evidence-Based Complementary Altern Med</source>. (<year>2013</year>) <volume>2013</volume>:<fpage>293248</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2013/293248</pub-id>, PMID: <pub-id pub-id-type="pmid">23983776</pub-id></citation></ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cramer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Anheyer</surname> <given-names>D</given-names>
</name>
<name>
<surname>Lauche</surname> <given-names>R</given-names>
</name>
<name>
<surname>Dobos</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>A systematic review of yoga for major depressive disorder</article-title>. <source>J Affect Disord</source>. (<year>2017</year>) <volume>213</volume>:<page-range>70&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jad.2017.02.006</pub-id>, PMID: <pub-id pub-id-type="pmid">28192737</pub-id></citation></ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cramer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Anheyer</surname> <given-names>D</given-names>
</name>
<name>
<surname>Saha</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Dobos</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Yoga for posttraumatic stress disorder - a systematic review and meta-analysis</article-title>. <source>BMC Psychiatry</source>. (<year>2018</year>) <volume>18</volume>:<fpage>72</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12888-018-1650-x</pub-id>, PMID: <pub-id pub-id-type="pmid">29566652</pub-id></citation></ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cramer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lauche</surname> <given-names>R</given-names>
</name>
<name>
<surname>Anheyer</surname> <given-names>D</given-names>
</name>
<name>
<surname>Pilkington</surname> <given-names>K</given-names>
</name>
<name>
<surname>de Manincor</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dobos</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Yoga for anxiety: A systematic review and meta-analysis of randomized controlled trials</article-title>. <source>Depress Anxiety</source>. (<year>2018</year>) <volume>35</volume>:<page-range>830&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/da.22762</pub-id>, PMID: <pub-id pub-id-type="pmid">29697885</pub-id></citation></ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fincham</surname> <given-names>GW</given-names>
</name>
<name>
<surname>Strauss</surname> <given-names>C</given-names>
</name>
<name>
<surname>Montero-Marin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cavanagh</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Effect of breathwork on stress and mental health: A meta-analysis of randomised-controlled trials</article-title>. <source>Sci Rep</source>. (<year>2023</year>) <volume>13</volume>:<fpage>432</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-022-27247-y</pub-id>, PMID: <pub-id pub-id-type="pmid">36624160</pub-id></citation></ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Page</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>McKenzie</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Bossuyt</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Boutron</surname> <given-names>I</given-names>
</name>
<name>
<surname>Hoffmann</surname> <given-names>TC</given-names>
</name>
<name>
<surname>Mulrow</surname> <given-names>CD</given-names>
</name>
<etal/>
</person-group>. <article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title>. <source>Br Med J</source>. (<year>2021</year>) <volume>372</volume>:<fpage>n71</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id>, PMID: <pub-id pub-id-type="pmid">33782057</pub-id></citation></ref>
<ref id="B14">
<label>14</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Higgins</surname> <given-names>JPT</given-names>
</name>
<name>
<surname>Thomas</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chandler</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cumpston</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T</given-names>
</name>
<name>
<surname>Page</surname> <given-names>MJ</given-names>
</name>
<etal/>
</person-group>. <source>Cochrane handbook for systematic reviews of interventions</source>. <edition>2nd</edition>. <publisher-loc>Chichester (UK)</publisher-loc>: <publisher-name>Wiley</publisher-name> (<year>2019</year>).</citation></ref>
<ref id="B15">
<label>15</label>
<citation citation-type="book">
<person-group person-group-type="author">
<collab>European Medicines Agency</collab>
</person-group>. <article-title>ICH harmonised tripartite guideline E6 (R1)</article-title>. In: <source>Step 5. Note for guidance on good clinical practice (CPMP/ICH/135/95)</source>. <publisher-name>European Medicines Agency</publisher-name>, <publisher-loc>London</publisher-loc> (<year>2002</year>).</citation></ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sterne</surname> <given-names>JAC</given-names>
</name>
<name>
<surname>Savovi&#x107;</surname> <given-names>J</given-names>
</name>
<name>
<surname>Page</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Elbers</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Blencowe</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Boutron</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>RoB 2: A revised tool for assessing risk of bias in randomised trials</article-title>. <source>Br Med J</source>. (<year>2019</year>) <volume>366</volume>:<fpage>l4898</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmj.l4898</pub-id>, PMID: <pub-id pub-id-type="pmid">31462531</pub-id></citation></ref>
<ref id="B17">
<label>17</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>McGuinness</surname>
</name>
<name>
<surname>Luke</surname> <given-names>A</given-names>
</name>
<name>
<surname>Higgins</surname> <given-names>JPT</given-names>
</name>
</person-group>. <source>RoBvis: Visualization tool for risk of bias assessments</source> (<year>2024</year>). Available online at: <uri xlink:href="https://www.riskofbias.info/welcome/robvis-visualization-tool">https://www.riskofbias.info/welcome/robvis-visualization-tool</uri> (Accessed March 28, 2025).</citation></ref>
<ref id="B18">
<label>18</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Ellis</surname> <given-names>PD</given-names>
</name>
</person-group>. <source>The essential guide to effect sizes: statistical power, meta-analysis, and the interpretation of research results</source>. <publisher-loc>Cambridge</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name> (<year>2012</year>).</citation></ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higgins</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>SG</given-names>
</name>
</person-group>. <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source>. (<year>2002</year>) <volume>21</volume>:<page-range>1539&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/sim.1186</pub-id>, PMID: <pub-id pub-id-type="pmid">12111919</pub-id></citation></ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carter</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gerbarg</surname> <given-names>P</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ware</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ambrosio</surname> <given-names>C</given-names>
</name>
<name>
<surname>Anand</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: Randomized controlled trial</article-title>. <source>J Traumatic Stress Disord Treat</source>. (<year>2013</year>) <volume>2</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4172/2324-8947.1000108</pub-id>
</citation></ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Descilo</surname> <given-names>T</given-names>
</name>
<name>
<surname>Vedamurtachar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gerbarg</surname> <given-names>PL</given-names>
</name>
<name>
<surname>Nagaraja</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gangadhar</surname> <given-names>BN</given-names>
</name>
<name>
<surname>Damodaran</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of a yoga breath intervention alone and in combination with an exposure therapy for post-traumatic stress disorder and depression in survivors of the 2004 South-East Asia tsunami</article-title>. <source>Acta Psychiatr Scand</source>. (<year>2010</year>) <volume>121</volume>:<fpage>289</fpage>&#x2013;<lpage>300</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-0447.2009.01466.x</pub-id>, PMID: <pub-id pub-id-type="pmid">19694633</pub-id></citation></ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franzblau</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Echevarria</surname> <given-names>S</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>M</given-names>
</name>
<name>
<surname>Van Cantfort</surname> <given-names>TE</given-names>
</name>
</person-group>. <article-title>A preliminary investigation of the effects of giving testimony and learning yogic breathing techniques on battered women&#x2019;s feelings of depression</article-title>. <source>J Interpers Violence</source>. (<year>2008</year>) <volume>23</volume>:<page-range>1800&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/0886260508314329</pub-id>, PMID: <pub-id pub-id-type="pmid">18319369</pub-id></citation></ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katzman</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Vermani</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gerbarg</surname> <given-names>PL</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Iorio</surname> <given-names>C</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>A multicomponent yoga-based, breath intervention program as an adjunctive treatment in patients suffering from generalized anxiety disorder with or without comorbidities</article-title>. <source>Int J Yoga</source>. (<year>2012</year>) <volume>5</volume>:<fpage>57</fpage>&#x2013;<lpage>65</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/0973-6131.91716</pub-id>, PMID: <pub-id pub-id-type="pmid">22346068</pub-id></citation></ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravindran</surname> <given-names>AV</given-names>
</name>
<name>
<surname>McKay</surname> <given-names>MS</given-names>
</name>
<name>
<surname>da Silva</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Tindall</surname> <given-names>C</given-names>
</name>
<name>
<surname>Garfinkel</surname> <given-names>T</given-names>
</name>
<name>
<surname>Paric</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Breathing-focused yoga as augmentation for unipolar and bipolar depression: A randomized controlled trial: Le yoga ax&#xe9; sur la respiration comme traitement d&#x2019;appoint pour la d&#xe9;pression unipolaire et bipolaire: Un essai randomis&#xe9; contr&#xf4;l&#xe9;</article-title>. <source>Can J Psychiatry</source>. (<year>2021</year>) <volume>66</volume>:<page-range>159&#x2013;69</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/0706743720940535</pub-id>, PMID: <pub-id pub-id-type="pmid">32677851</pub-id></citation></ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>A</given-names>
</name>
<name>
<surname>Barrett</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Cucchiara</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Gooneratne</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Thase</surname> <given-names>ME</given-names>
</name>
</person-group>. <article-title>A breathing-based meditation intervention for patients with major depressive disorder following inadequate response to antidepressants: A randomized pilot study</article-title>. <source>J Clin Psychiatry</source>. (<year>2017</year>) <volume>78</volume>:<page-range>e59&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4088/JCP.16m10819</pub-id>, PMID: <pub-id pub-id-type="pmid">27898207</pub-id></citation></ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shetty</surname> <given-names>KT</given-names>
</name>
<name>
<surname>Subbakrishna</surname> <given-names>D</given-names>
</name>
<name>
<surname>Meti</surname> <given-names>B</given-names>
</name>
<name>
<surname>Raju</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Therapeutic efficacy of sudarshan kriya yoga (SKK) in dysthymic disorder</article-title>. <source>Nimhans J</source>. (<year>1998</year>) <volume>16</volume>(<issue>1</issue>):<page-range>21&#x2013;8</page-range>.</citation></ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhargav</surname> <given-names>H</given-names>
</name>
<name>
<surname>Nagendra</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Gangadhar</surname> <given-names>BN</given-names>
</name>
<name>
<surname>Nagarathna</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Frontal hemodynamic responses to high frequency yoga breathing in schizophrenia: a functional near-infrared spectroscopy study</article-title>. <source>Front Psychiatry</source>. (<year>2014</year>) <volume>5</volume>:<fpage>29</fpage>.</citation></ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhardwaj</surname> <given-names>P</given-names>
</name>
<name>
<surname>Pathania</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bahurupi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kanchibhotla</surname> <given-names>D</given-names>
</name>
<name>
<surname>Harsora</surname> <given-names>P</given-names>
</name>
<name>
<surname>Rathaur</surname> <given-names>VK</given-names>
</name>
</person-group>. <article-title>Efficacy of mHealth aided 12-week meditation and breath intervention on change in burnout and professional quality of life among health care providers of a tertiary care hospital in north India: a randomized waitlist-controlled trial</article-title>. <source>Front Public Health</source>. (<year>2023</year>) <volume>11</volume>:<elocation-id>1258330</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpubh.2023.1258330</pub-id>, PMID: <pub-id pub-id-type="pmid">38026380</pub-id></citation></ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayley</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Schulz-Heik</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Mathersul</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Avery</surname> <given-names>T</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Randomised clinical non-inferiority trial of breathing-based meditation and cognitive processing therapy for symptoms of post-traumatic stress disorder in military veterans</article-title>. <source>Br Med J Open</source>. (<year>2022</year>) <volume>12</volume>:<fpage>e056609</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmjopen-2021-056609</pub-id>, PMID: <pub-id pub-id-type="pmid">36008059</pub-id></citation></ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulz-Heik</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Lazzeroni</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Hernandez</surname> <given-names>B</given-names>
</name>
<name>
<surname>Avery</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Mathersul</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>JS</given-names>
</name>
<etal/>
</person-group>. <article-title>Valued living among veterans in breath-based meditation treatment or cognitive processing therapy for posttraumatic stress disorder: Exploratory outcome of a randomized controlled trial</article-title>. <source>Global Adv Integr Med Health</source>. (<year>2022</year>) <volume>11</volume>:<fpage>2164957x221108376</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/2164957X221108376</pub-id>, PMID: <pub-id pub-id-type="pmid">35770246</pub-id></citation></ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haller</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mitzinger</surname> <given-names>D</given-names>
</name>
<name>
<surname>Cramer</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>The integration of yoga breathing techniques in cognitive behavioral therapy for post-traumatic stress disorder: A pragmatic randomized controlled trial</article-title>. <source>Front Psychiatry</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1101046</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpsyt.2023.1101046</pub-id>, PMID: <pub-id pub-id-type="pmid">37139325</pub-id></citation></ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janakiramaiah</surname> <given-names>N</given-names>
</name>
<name>
<surname>Gangadhar</surname> <given-names>BN</given-names>
</name>
<name>
<surname>Naga Venkatesha Murthy</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Harish</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Subbakrishna</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Vedamurthachar</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Antidepressant efficacy of sudarshan kriya yoga (SKY) in melancholia: A randomized comparison with electroconvulsive therapy (ECT) and imipramine</article-title>. <source>J Affect Disord</source>. (<year>2000</year>) <volume>57</volume>:<page-range>255&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0165-0327(99)00079-8</pub-id>, PMID: <pub-id pub-id-type="pmid">10708840</pub-id></citation></ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sepp&#xe4;l&#xe4;</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Nitschke</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Tudorascu</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Hayes</surname> <given-names>A</given-names>
</name>
<name>
<surname>Goldstein</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Nguyen</surname> <given-names>DT</given-names>
</name>
<etal/>
</person-group>. <article-title>Breathing-based meditation decreases posttraumatic stress disorder symptoms in U.S. military veterans: A randomized controlled longitudinal study</article-title>. <source>J Traumatic Stress</source>. (<year>2014</year>) <volume>27</volume>:<fpage>397</fpage>&#x2013;<lpage>405</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jts.21936</pub-id>, PMID: <pub-id pub-id-type="pmid">25158633</pub-id></citation></ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sureka</surname> <given-names>P</given-names>
</name>
<name>
<surname>Govil</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dash</surname> <given-names>D</given-names>
</name>
<name>
<surname>Dash</surname> <given-names>C</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>M</given-names>
</name>
<name>
<surname>Singhal</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Effect of sudarshan kriya on male prisoners with non psychotic psychiatric disorders: A randomized control trial</article-title>. <source>Asian J Psychiatry</source>. (<year>2014</year>) <volume>12</volume>:<page-range>43&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajp.2014.06.010</pub-id>, PMID: <pub-id pub-id-type="pmid">25440560</pub-id></citation></ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vedamurthachar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Janakiramaiah</surname> <given-names>N</given-names>
</name>
<name>
<surname>Hegde</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Shetty</surname> <given-names>TK</given-names>
</name>
<name>
<surname>Subbakrishna</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Sureshbabu</surname> <given-names>SV</given-names>
</name>
<etal/>
</person-group>. <article-title>Antidepressant efficacy and hormonal effects of sudarshana kriya yoga (SKY) in alcohol dependent individuals</article-title>. <source>J Affect Disord</source>. (<year>2006</year>) <volume>94</volume>:<page-range>249&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jad.2006.04.025</pub-id>, PMID: <pub-id pub-id-type="pmid">16740317</pub-id></citation></ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banushi</surname> <given-names>B</given-names>
</name>
<name>
<surname>Brendle</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ragnhildstveit</surname> <given-names>A</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>T</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>C</given-names>
</name>
<name>
<surname>Egberts</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Breathwork interventions for adults with clinically diagnosed anxiety disorders: A scoping review</article-title>. <source>Brain Sci</source>. (<year>2023</year>) <volume>94</volume>(<issue>1-3</issue>):<page-range>249&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/brainsci13020256</pub-id>, PMID: <pub-id pub-id-type="pmid">36831799</pub-id></citation></ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharpe</surname> <given-names>E</given-names>
</name>
<name>
<surname>Lacombe</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sadowski</surname> <given-names>A</given-names>
</name>
<name>
<surname>Phipps</surname> <given-names>J</given-names>
</name>
<name>
<surname>Heer</surname> <given-names>R</given-names>
</name>
<name>
<surname>Rajurkar</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Investigating components of pranayama for effects on heart rate variability</article-title>. <source>J Psychosomatic Res</source>. (<year>2021</year>) <volume>148</volume>:<fpage>110569</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jpsychores.2021.110569</pub-id>, PMID: <pub-id pub-id-type="pmid">34271528</pub-id></citation></ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaccaro</surname> <given-names>A</given-names>
</name>
<name>
<surname>Piarulli</surname> <given-names>A</given-names>
</name>
<name>
<surname>Laurino</surname> <given-names>M</given-names>
</name>
<name>
<surname>Garbella</surname> <given-names>E</given-names>
</name>
<name>
<surname>Menicucci</surname> <given-names>D</given-names>
</name>
<name>
<surname>Neri</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>How breath-control can change your life: A systematic review on psycho-physiological correlates of slow breathing</article-title>. <source>Front Hum Neurosci</source>. (<year>2018</year>) <volume>12</volume>:<elocation-id>353</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnhum.2018.00353</pub-id>, PMID: <pub-id pub-id-type="pmid">30245619</pub-id></citation></ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kox</surname> <given-names>M</given-names>
</name>
<name>
<surname>van Eijk</surname> <given-names>LT</given-names>
</name>
<name>
<surname>Zwaag</surname> <given-names>J</given-names>
</name>
<name>
<surname>van den Wildenberg</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sweep</surname> <given-names>FC</given-names>
</name>
<name>
<surname>van der Hoeven</surname> <given-names>JG</given-names>
</name>
<etal/>
</person-group>. <article-title>Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans</article-title>. <source>Proc Natl Acad Sci U S A</source>. (<year>2014</year>) <volume>111</volume>:<page-range>7379&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1322174111</pub-id>, PMID: <pub-id pub-id-type="pmid">24799686</pub-id></citation></ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haller</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ostermann</surname> <given-names>T</given-names>
</name>
<name>
<surname>Lauche</surname> <given-names>R</given-names>
</name>
<name>
<surname>Cramer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Dobos</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Credibility of a comparative sham control intervention for Craniosacral Therapy in patients with chronic neck pain</article-title>. <source>Complement Ther Med</source>. (<year>2014</year>) <volume>22</volume>:<page-range>1053&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ctim.2014.09.007</pub-id>, PMID: <pub-id pub-id-type="pmid">25453528</pub-id></citation></ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cramer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lauche</surname> <given-names>R</given-names>
</name>
<name>
<surname>Langhorst</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dobos</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Are Indian yoga trials more likely to be positive than those from other countries? A systematic review of randomized controlled trials</article-title>. <source>Contemp Clin Trials</source>. (<year>2015</year>) <volume>41</volume>:<page-range>269&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cct.2015.02.005</pub-id>, PMID: <pub-id pub-id-type="pmid">25705015</pub-id></citation></ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Junqueira</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Zorzela</surname> <given-names>L</given-names>
</name>
<name>
<surname>Golder</surname> <given-names>S</given-names>
</name>
<name>
<surname>Loke</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gagnier</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Julious</surname> <given-names>SA</given-names>
</name>
<etal/>
</person-group>. <article-title>CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials</article-title>. <source>J Clin Epidemiol</source>. (<year>2023</year>) <volume>158</volume>:<page-range>149&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jclinepi.2023.04.005</pub-id>, PMID: <pub-id pub-id-type="pmid">37100738</pub-id></citation></ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moher</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hopewell</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schulz</surname> <given-names>KF</given-names>
</name>
<name>
<surname>Montori</surname> <given-names>V</given-names>
</name>
<name>
<surname>G&#xf8;tzsche</surname> <given-names>PC</given-names>
</name>
<name>
<surname>Devereaux</surname> <given-names>PJ</given-names>
</name>
<etal/>
</person-group>. <article-title>CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials</article-title>. <source>J Clin Epidemiol</source>. (<year>2010</year>) <volume>63</volume>:<fpage>e1</fpage>&#x2013;<lpage>37</lpage>.</citation></ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ward</surname> <given-names>L</given-names>
</name>
<name>
<surname>Nault</surname> <given-names>D</given-names>
</name>
<name>
<surname>Cramer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Moonaz</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Development of the CLARIFY (checklist standardising the reporting of interventions for yoga) guidelines: A delphi study</article-title>. <source>Br Med J Open</source>. (<year>2022</year>) <volume>12</volume>:<fpage>e054585</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmjopen-2021-054585</pub-id>, PMID: <pub-id pub-id-type="pmid">35105638</pub-id></citation></ref>
<ref id="B45">
<label>45</label>
<citation citation-type="book">
<person-group person-group-type="author">
<collab>European Institute for Gender Equality (EIGE)</collab>
</person-group>. <person-group person-group-type="author">
<name>
<surname>Franklin</surname> <given-names>P</given-names>
</name>
</person-group>. <source>Gender Equality Index 2021: Health</source>. <publisher-loc>Luxembourg</publisher-loc>: <publisher-name>Publications Office of the European Union</publisher-name> (<year>2021</year>). Available online at: <uri xlink:href="https://eige.europa.eu/publications/gender-equality-index-2021-health">https://eige.europa.eu/publications/gender-equality-index-2021-health</uri>.</citation></ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berenz</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Vujanovic</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Coffey</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Zvolensky</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>Anxiety sensitivity and breath-holding duration in relation to PTSD symptom severity among trauma exposed adults</article-title>. <source>J Anxiety Disord</source>. (<year>2012</year>) <volume>26</volume>:<page-range>134&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.janxdis.2011.10.004</pub-id>, PMID: <pub-id pub-id-type="pmid">22047652</pub-id></citation></ref>
</ref-list>
</back>
</article>